Prenetics Global Limited

4.09
0.03 (0.74%)
At close: Mar 24, 2025, 3:58 PM
4.15
1.47%
After-hours: Mar 24, 2025, 06:53 PM EDT
0.74%
Bid 2.78
Market Cap 49.97M
Revenue (ttm) 24.58M
Net Income (ttm) -47.13M
EPS (ttm) -3.73
PE Ratio (ttm) -1.1
Forward PE -9.46
Analyst Buy
Ask 4.31
Volume 852
Avg. Volume (20D) 12,024
Open 4.06
Previous Close 4.06
Day's Range 4.06 - 4.20
52-Week Range 2.85 - 7.84
Beta -0.31

About PRE

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...

Sector Healthcare
IPO Date Jul 16, 2021
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRE
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 120.05% from the latest price.

Stock Forecasts
5 months ago
+19.13%
Prenetics Global shares are trading higher followi... Unlock content with Pro Subscription
7 months ago
+5.47%
Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.